The oxygen therapy market size has grown strongly in recent years. It will grow from $28.42 billion in 2024 to $30.97 billion in 2025 at a compound annual growth rate (CAGR) of 9%. The growth in the historic period can be attributed to increased prevalence of respiratory diseases and disorders, growing geriatric population globally, government initiatives promoting healthcare infrastructure, expansion of home healthcare services, increased smoking-related health issues.
The oxygen therapy market size is expected to see rapid growth in the next few years. It will grow to $46.4 billion in 2029 at a compound annual growth rate (CAGR) of 10.6%. The growth in the forecast period can be attributed to innovative devices, personalized medicine, R&D investments, climate change impact, sports and fitness. Major trends in the forecast period include value-based care models, regulatory advances, patient education initiatives, alternative oxygen delivery models, patient-centric design.
The rising prevalence of tobacco smoking is anticipated to drive the growth of the oxygen therapy market in the future. Tobacco smoking involves burning tobacco to inhale its smoke, which is absorbed into the bloodstream. Individuals suffering from smoking-related respiratory diseases often face breathing difficulties and lower oxygen levels in their blood. Oxygen therapy is a vital intervention that provides supplemental oxygen, helping to alleviate breathing challenges and enhance oxygen saturation levels. For instance, in December 2023, the National Health Service, a UK-based government department, reported approximately 408,700 hospital admissions related to smoking in 2022-23, up from 389,800 in 2021-22, marking an increase of 4.8%. Thus, the increasing prevalence of tobacco smoking is fueling the growth of the oxygen therapy market.
The escalating incidence of respiratory disorders is expected to contribute to the expansion of the oxygen therapy market. Respiratory disorders, including lung diseases such as tuberculosis, lung cancer, mesothelioma, cystic fibrosis, and asthma, impact the respiratory system and often result in difficulties breathing. Oxygen therapy is a vital treatment for individuals with respiratory disorders, providing an additional supply of oxygen to relieve shortness of breath. According to a report by the American Lung Association in February 2023, over 34 million Americans suffer from chronic lung illnesses, including asthma and chronic obstructive pulmonary disease (COPD), emphasizing the growing demand for oxygen therapy.
Major players in the oxygen therapy market are responding to the increasing demand by developing innovative products. One notable development is the introduction of portable oxygen concentrators designed to cater to individuals with breathing-related disorders. These devices, such as the Oxlife Liberty launched by O2 Concepts in October 2022, are compact and lightweight, delivering continuous and adjustable oxygen supply. The Oxlife Liberty features advanced technology, including Dynamic Network Analysis (DNA) Technology, enhancing operational efficiency and providing a personalized oxygen therapy experience. The market's focus on innovation in portable oxygen concentrators reflects a commitment to meeting the diverse needs of patients with respiratory conditions.
Technological advancements are a prominent trend in the oxygen therapy market, with companies adopting new technologies to maintain their competitive edge. For example, Omron Healthcare introduced a portable oxygen concentrator in July 2022, utilizing Pressure Swing Adsorption (PSA) technology to ensure a continuous supply of oxygen at 5L per minute. This technology maintains oxygen efficiency and purity while enhancing the device's mobility for easier transport.
In January 2023, CAIRE Inc., a U.S.-based medical equipment manufacturing company, completed the acquisition of MGC Diagnostics, a move aimed at strengthening CAIRE Inc.'s diagnostic technologies portfolio to better serve patients with pulmonary diseases. MGC Diagnostics, a U.S.-based company specializing in oxygen therapy tools such as pulse oximeters, adds value to CAIRE Inc.'s commitment to providing comprehensive solutions in the field of respiratory care.
Major companies operating in the oxygen therapy market include Smiths Medical Inc., Hersill SL, Fisher & Paykel Healthcare Corporation Limited, Invacare Corporation, Teleflex Incorporated, Koninklijke Philips N.V., Drive Devilbiss International, Allied Healthcare Products Inc., Becton Dickinson and Company, General Electric Company, Getinge Group, Essex Industries Inc., Chart Industries Inc., Drägerwerk AG & Co. KGaA, Gas Control Equipment Group, Thermo Fisher Scientific Inc., OxyBand Technologies Inc., Nidek Medical Products Inc., Linde Healthcare, Taiyo Nippon Sanso Corporation, Inogen Inc., Heinen + Löwenstein GmbH & Co. KG, Messer Medical Austria GmbH, TECNO-GAZ S.p.A, HUM - Gesellschaft für Homecare und Medizintechnik mbH, medicap homecare GmbH, GCE Holding AB, Salter Labs, Vyaire Medical Inc., CAIRE Inc., Precision Medical Inc., O2 Concepts LLC, AirSep Corporation.
North America was the largest region in the oxygen therapy market in 2024. The regions covered in the oxygen therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the oxygen therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Oxygen therapy involves the administration of additional oxygen as part of the management of illnesses in individuals experiencing respiratory issues, preventing them from naturally obtaining sufficient oxygen due to various diseases and conditions. This therapeutic approach ensures that individuals with lung disorders or breathing difficulties receive the necessary oxygen to sustain bodily functions.
The primary categories of oxygen therapy products encompass oxygen delivery devices and oxygen source equipment. Oxygen delivery devices serve as secondary means of supplying oxygen to individuals unable to maintain a safe level of oxygen saturation. In oxygen therapy, devices for controlling and monitoring respiratory failure include nasal or transtracheal catheters and nasal cannula. These devices exhibit various levels of portability, ranging from stationary devices to portable ones, and find applications in conditions such as pneumonia, chronic obstructive pulmonary disease, asthma, obstructive sleep apnea, respiratory distress syndrome, cystic fibrosis, among others. The utilization of these devices extends across diverse settings, including hospitals, clinics, home care, and post-acute care facilities.
The oxygen therapy market research report is one of a series of new reports that provides oxygen therapy market statistics, including the oxygen therapy industry global market size, regional shares, competitors with an oxygen therapy market share, detailed oxygen therapy market segments, market trends, and opportunities, and any further data you may need to thrive in the oxygen therapy industry. This oxygen therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The oxygen therapy market consists of sales of pulse oximeters, oxygen flow meters, portable oxygen supply devices, nasal cannulas, simple masks, non-rebreather masks, continuous positive airway pressure, BiPAP, bag valve mask (ambu bag), endotracheal intubation, and mechanical ventilator. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
The oxygen therapy market size is expected to see rapid growth in the next few years. It will grow to $46.4 billion in 2029 at a compound annual growth rate (CAGR) of 10.6%. The growth in the forecast period can be attributed to innovative devices, personalized medicine, R&D investments, climate change impact, sports and fitness. Major trends in the forecast period include value-based care models, regulatory advances, patient education initiatives, alternative oxygen delivery models, patient-centric design.
The rising prevalence of tobacco smoking is anticipated to drive the growth of the oxygen therapy market in the future. Tobacco smoking involves burning tobacco to inhale its smoke, which is absorbed into the bloodstream. Individuals suffering from smoking-related respiratory diseases often face breathing difficulties and lower oxygen levels in their blood. Oxygen therapy is a vital intervention that provides supplemental oxygen, helping to alleviate breathing challenges and enhance oxygen saturation levels. For instance, in December 2023, the National Health Service, a UK-based government department, reported approximately 408,700 hospital admissions related to smoking in 2022-23, up from 389,800 in 2021-22, marking an increase of 4.8%. Thus, the increasing prevalence of tobacco smoking is fueling the growth of the oxygen therapy market.
The escalating incidence of respiratory disorders is expected to contribute to the expansion of the oxygen therapy market. Respiratory disorders, including lung diseases such as tuberculosis, lung cancer, mesothelioma, cystic fibrosis, and asthma, impact the respiratory system and often result in difficulties breathing. Oxygen therapy is a vital treatment for individuals with respiratory disorders, providing an additional supply of oxygen to relieve shortness of breath. According to a report by the American Lung Association in February 2023, over 34 million Americans suffer from chronic lung illnesses, including asthma and chronic obstructive pulmonary disease (COPD), emphasizing the growing demand for oxygen therapy.
Major players in the oxygen therapy market are responding to the increasing demand by developing innovative products. One notable development is the introduction of portable oxygen concentrators designed to cater to individuals with breathing-related disorders. These devices, such as the Oxlife Liberty launched by O2 Concepts in October 2022, are compact and lightweight, delivering continuous and adjustable oxygen supply. The Oxlife Liberty features advanced technology, including Dynamic Network Analysis (DNA) Technology, enhancing operational efficiency and providing a personalized oxygen therapy experience. The market's focus on innovation in portable oxygen concentrators reflects a commitment to meeting the diverse needs of patients with respiratory conditions.
Technological advancements are a prominent trend in the oxygen therapy market, with companies adopting new technologies to maintain their competitive edge. For example, Omron Healthcare introduced a portable oxygen concentrator in July 2022, utilizing Pressure Swing Adsorption (PSA) technology to ensure a continuous supply of oxygen at 5L per minute. This technology maintains oxygen efficiency and purity while enhancing the device's mobility for easier transport.
In January 2023, CAIRE Inc., a U.S.-based medical equipment manufacturing company, completed the acquisition of MGC Diagnostics, a move aimed at strengthening CAIRE Inc.'s diagnostic technologies portfolio to better serve patients with pulmonary diseases. MGC Diagnostics, a U.S.-based company specializing in oxygen therapy tools such as pulse oximeters, adds value to CAIRE Inc.'s commitment to providing comprehensive solutions in the field of respiratory care.
Major companies operating in the oxygen therapy market include Smiths Medical Inc., Hersill SL, Fisher & Paykel Healthcare Corporation Limited, Invacare Corporation, Teleflex Incorporated, Koninklijke Philips N.V., Drive Devilbiss International, Allied Healthcare Products Inc., Becton Dickinson and Company, General Electric Company, Getinge Group, Essex Industries Inc., Chart Industries Inc., Drägerwerk AG & Co. KGaA, Gas Control Equipment Group, Thermo Fisher Scientific Inc., OxyBand Technologies Inc., Nidek Medical Products Inc., Linde Healthcare, Taiyo Nippon Sanso Corporation, Inogen Inc., Heinen + Löwenstein GmbH & Co. KG, Messer Medical Austria GmbH, TECNO-GAZ S.p.A, HUM - Gesellschaft für Homecare und Medizintechnik mbH, medicap homecare GmbH, GCE Holding AB, Salter Labs, Vyaire Medical Inc., CAIRE Inc., Precision Medical Inc., O2 Concepts LLC, AirSep Corporation.
North America was the largest region in the oxygen therapy market in 2024. The regions covered in the oxygen therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the oxygen therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Oxygen therapy involves the administration of additional oxygen as part of the management of illnesses in individuals experiencing respiratory issues, preventing them from naturally obtaining sufficient oxygen due to various diseases and conditions. This therapeutic approach ensures that individuals with lung disorders or breathing difficulties receive the necessary oxygen to sustain bodily functions.
The primary categories of oxygen therapy products encompass oxygen delivery devices and oxygen source equipment. Oxygen delivery devices serve as secondary means of supplying oxygen to individuals unable to maintain a safe level of oxygen saturation. In oxygen therapy, devices for controlling and monitoring respiratory failure include nasal or transtracheal catheters and nasal cannula. These devices exhibit various levels of portability, ranging from stationary devices to portable ones, and find applications in conditions such as pneumonia, chronic obstructive pulmonary disease, asthma, obstructive sleep apnea, respiratory distress syndrome, cystic fibrosis, among others. The utilization of these devices extends across diverse settings, including hospitals, clinics, home care, and post-acute care facilities.
The oxygen therapy market research report is one of a series of new reports that provides oxygen therapy market statistics, including the oxygen therapy industry global market size, regional shares, competitors with an oxygen therapy market share, detailed oxygen therapy market segments, market trends, and opportunities, and any further data you may need to thrive in the oxygen therapy industry. This oxygen therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The oxygen therapy market consists of sales of pulse oximeters, oxygen flow meters, portable oxygen supply devices, nasal cannulas, simple masks, non-rebreather masks, continuous positive airway pressure, BiPAP, bag valve mask (ambu bag), endotracheal intubation, and mechanical ventilator. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
1. Executive Summary2. Oxygen Therapy Market Characteristics3. Oxygen Therapy Market Trends and Strategies4. Oxygen Therapy Market - Macro Economic Scenario Including the Impact of Interest Rates, Inflation, Geopolitics, and the Recovery from COVID-19 on the Market32. Global Oxygen Therapy Market Competitive Benchmarking and Dashboard33. Key Mergers and Acquisitions in the Oxygen Therapy Market34. Recent Developments in the Oxygen Therapy Market
5. Global Oxygen Therapy Growth Analysis and Strategic Analysis Framework
6. Oxygen Therapy Market Segmentation
7. Oxygen Therapy Market Regional and Country Analysis
8. Asia-Pacific Oxygen Therapy Market
9. China Oxygen Therapy Market
10. India Oxygen Therapy Market
11. Japan Oxygen Therapy Market
12. Australia Oxygen Therapy Market
13. Indonesia Oxygen Therapy Market
14. South Korea Oxygen Therapy Market
15. Western Europe Oxygen Therapy Market
16. UK Oxygen Therapy Market
17. Germany Oxygen Therapy Market
18. France Oxygen Therapy Market
19. Italy Oxygen Therapy Market
20. Spain Oxygen Therapy Market
21. Eastern Europe Oxygen Therapy Market
22. Russia Oxygen Therapy Market
23. North America Oxygen Therapy Market
24. USA Oxygen Therapy Market
25. Canada Oxygen Therapy Market
26. South America Oxygen Therapy Market
27. Brazil Oxygen Therapy Market
28. Middle East Oxygen Therapy Market
29. Africa Oxygen Therapy Market
30. Oxygen Therapy Market Competitive Landscape and Company Profiles
31. Oxygen Therapy Market Other Major and Innovative Companies
35. Oxygen Therapy Market High Potential Countries, Segments and Strategies
36. Appendix
Executive Summary
Oxygen Therapy Global Market Report 2025 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on oxygen therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for oxygen therapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The oxygen therapy market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- the market characteristics section of the report defines and explains the market.
- the market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- the forecasts are made after considering the major factors currently impacting the market. These include:
- the forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- the regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- the competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- the trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
1) by Product: Oxygen Delivery Devices; Oxygen Source Equipment2) by Portability: Stationary Devices; Portable Devices
3) by Application: Pneumonia; Chronic Obstructive Pulmonary Disease; Asthma; Obstructive Sleep Apnea; Respiratory Distress Syndrome; Cystic Fibrosis; Other Applications
4) by End User: Hospitals; Clinics; Home Care; Post Acute Care Settings
Subsegments:
1) by Oxygen Delivery Devices: Nasal Cannulas; Oxygen Masks; Venturi Masks; Non-Rebreather Masks2) by Oxygen Source Equipment: Oxygen Concentrators; Compressed Oxygen Cylinders; Liquid Oxygen Systems; Portable Oxygen Systems
Key Companies Mentioned: Smiths Medical Inc.; Hersill SL; Fisher & Paykel Healthcare Corporation Limited; Invacare Corporation; Teleflex Incorporated
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Companies Mentioned
Some of the major companies featured in this Oxygen Therapy market report include:- Smiths Medical Inc.
- Hersill SL
- Fisher & Paykel Healthcare Corporation Limited
- Invacare Corporation
- Teleflex Incorporated
- Koninklijke Philips N.V.
- Drive Devilbiss International
- Allied Healthcare Products Inc.
- Becton Dickinson and Company
- General Electric Company
- Getinge Group
- Essex Industries Inc.
- Chart Industries Inc.
- Drägerwerk AG & Co. KGaA
- Gas Control Equipment Group
- Thermo Fisher Scientific Inc.
- OxyBand Technologies Inc.
- Nidek Medical Products Inc.
- Linde Healthcare
- Taiyo Nippon Sanso Corporation
- Inogen Inc.
- Heinen + Löwenstein GmbH & Co. KG
- Messer Medical Austria GmbH
- TECNO-GAZ S.p.A
- HUM - Gesellschaft für Homecare und Medizintechnik mbH
- medicap homecare GmbH
- GCE Holding AB
- Salter Labs
- Vyaire Medical Inc.
- CAIRE Inc.
- Precision Medical Inc.
- O2 Concepts LLC
- AirSep Corporation
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | February 2025 |
| Forecast Period | 2025 - 2029 |
| Estimated Market Value ( USD | $ 30.97 Billion |
| Forecasted Market Value ( USD | $ 46.4 Billion |
| Compound Annual Growth Rate | 10.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 34 |
